METHODS FOR USING EXOSOMES TO MONITOR TRANSPLANTED ORGAN STATUS

Device and Methods

ANTI-DLL3 ANTIBODY AND PREPARATION METHOD THEREFOR, DRUG CONJUGATE AND APPLICATION THEREOF

Use of L-cysteine for improving the structure and function of gastric mucosa

ASSESSMENT AND DETECTION OF PORTAL VEIN THROMBOSIS IN CHRONIC LIVER DISEASE AND STAGING THEREOF

METHOD FOR DETERMINATION OF MUTATED FORM OF MUCIN-1 PROTEIN IN A BIOLOGICAL SAMPLE

BIOMARKERS FOR DETECTING SYNOVIAL JOINT DISEASE IN MUCOPOLYSACCHARIDOSES

METHODS OF TRACKING DONOR CELLS IN A RECIPIENT

INFORMATIVE BIOMARKERS OF PORTAL HYPERTENSION

LOT RELEASE ASSAYS FOR IGF-1/IGFBP COMPLEXES

METHODS OF PREPARING AND ANALYZING SAMPLES FOR BIOMARKERS ASSOCIATED WITH PLACENTA ACCRETA

USE OF HYPOXIA-INDUCIBLE FACTOR 1 ALPHA AS MARKER IN DEPRESSION RECURRENCE DIAGNOSIS

IDENTIFICATION OF UNIQUE BLOOD-BASED GENE EXPRESSION PROFILES IN CHILDREN WITH REGRESSIVE AUTISM SPECTRUM DISORDER (ASD) AND ILEOCOLITIS

THYROGLOBULIN QUANTITATION BY MASS SPECTROMETRY

FAB-LINKED GLYCANS AS BIOMARKER FOR THE TRANSITION FROM A PRE DISEASE "AT-RISK-PHASE" TO RHEUMATOID ARTHRITIS, AAV OR SJÖGREN SYNDROME

Antigens Derived from Citrullinated 14-3-3 and Uses Thereof in the Diagnosis of Rheumatoid Arthritis

DISEASE DETECTION WITH COMBINATORIAL BIOMARKERS

ANTIBODY MOLECULE AGAINST GROWTH AND DIFFERENTIATION FACTOR 15 AND USE THEREOF

COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEPRESSION

Assay device for diagnosis of open-globe ocular injuries

METHODS FOR QUANTIFYING FRATAXIN ACTIVITY

Collagen Type XXII Assay

Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases

EPIGENTIC REGULATION AND CO-TARGETING APPROACHES OF PSMA IN PROSTRATE CANCER

METALLIC CLUSTER MODIFIED NANOPORE SENSING FOR PEPTIDE DETECTION

COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEPRESSION

DIAGNOSTIC METHODS FOR CARDIOVASCULAR DISEASES

NOVEL ASSAY AND NOVEL METHODS OF TREATING HUTCHINSON-GILFORD PROGERIA SYNDROME

CARDIAC CALCIUM HANDLING MACHINERY REMODELED IN FRIEDREICH'S ATAXIA

GLX-DERIVED MOLECULE DETECTION

MIMOTOPES OF ARA H 2 AND USES OF THE SAME TO DIAGNOSE PEANUT ALLERGIES

IN VITRO METHODS FOR DETECTING DLL1

Use of PD-L1 Low Expression Status to Select Subjects for Cancer Immunotherapy

ANIMAL, FUNGAL AND MARINE SOURCES OF CGP AND INCREASED CGP CONCENTRATION FOR DISEASE MANAGEMENT AND FOR TREATMENT OF NON-NEUROLOGICAL AND/OR NEUROLOGICAL CONDITIONS

USE OF RPN11 MARKER IN DETECTION OF MYELOMA AND DISEASE RISK THEREOF, PROGNOSIS ANALYSIS AND TREATMENT MEDICAMENT

CEA ASSAY FOR PATIENT SELECTION IN CANCER THERAPY

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER

METHODS AND COMPOSITIONS FOR TREATING LIVER DISEASE

System for Detection, Monitoring, and Treatment of Kidney Disease

COMPOSITIONS AND METHODS FOR DIAGNOSING AND/OR TREATING CHRONIC KIDNEY DISEASE

COMPOSITIONS AND METHODS FOR DETECTING CADHERIN-17 PROTEIN

MR-PROADM MARKER PANELS FOR EARLY DETECTION OF SEPSIS

Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression

USE OF A PHARMACEUTICAL COMPOSITION

CNP Therapy

METHOD OF TREATING SEVERE GRAFT VERSUS HOST DISEASE

METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS

BIOMARKER COMPOSITIONS AND METHODS OF USE THEREOF

SYSTEMS AND METHODS FOR THE ANALYSIS OF BIOLOGICAL SAMPLES

TREATMENT OF CANCER WITH KDM4 INHIBITORS

CANCER LESION TISSUE EVALUATION FOR OPTIMIZING EFFECT OF BORON NEUTRON CAPTURE THERAPY

DEVELOPMENT OF MICROBIAL BIOSENSORS FOR INTESTINAL INFLAMMATION

METHODS FOR AIDING IN THE DIAGNOSIS AND EVALUATION OF A SUBJECT WHO HAS SUSTAINED AN ORTHOPEDIC INJURY AND THAT HAS OR MAY HAVE SUSTAINED AN INJURY TO THE HEAD, SUCH AS MILD TRAUMATIC BRAIN INJURY (TBI), USING GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) AND/OR UBIQUITIN CARBOXY-TERMINAL HYDROLASE L1 (UCH-L1)

METHODS FOR AIDING IN THE DETERMINATION OF WHETHER TO PERFORM IMAGING ON A HUMAN SUBJECT WHO HAS SUSTAINED OR MAY HAVE SUSTAINED AN INJURY TO THE HEAD USING EARLY BIOMARKERS

DIAGNOSTICS OF MILD OR ADVANCED PERIODONTITIS BASED ON SALIVARY IL-1BETA AND MMP-9

METHOD FOR THE MANAGEMENT OF ANTIBIOTIC ADMINISTRATION

GLOMERULONEPHRITIS BIOMARKERS

TREATMENT FOR INFLAMMATORY DISEASE

TRANSTHYRETIN (TTR) MONOMER BINDING ANTIBODIES

METHODS FOR THE TREATMENT OF HUNTER SYNDROME

BIOMARKER SIGNATURES INDICATIVE OF EARLY STAGES OF CANCER

METHOD AND SYSTEM FOR ANALYSING A BIOLOGICAL SAMPLE

Biomarker for Detecting Hepatocytes With Bile Ductular Proliferation

Methods of using anti-SP17 immunotherapeutics

TREATMENT AND DIAGNOSIS OF DISEASES ASSOCIATED TO PATHOGENIC FIBROSIS

ENDOTHELIN RECEPTOR ANTAGONISTS FOR USE IN TREATING OR PREVENTING MUSCLE FIBROSIS

BIOMARKERS OF HIDDEN OBESITY FOR USE IN PREVENTATIVE HEALTHCARE

K17 AS A BIOMARKER FOR TUMOR RESPONSE TO IMMUNOTHERAPY

IMPROVED METHODS FOR DETECTING AND TREATING ENDOMETRIOSIS

DETECTION OF GLYCATED ALBUMIN IN DIABETES-AFFECTED BIOLOGICAL SAMPLES

SYSTEMS AND METHODS FOR PREDICTING DISEASES

COMPOSITIONS AND METHODS FOR TREATMENT OF MIC60 DEPLETED CANCERS AND METASTASIS

TREATMENT OF LUPUS NEPHRITIS WITH ANTI-TYPE I INF RECEPTOR ANTIBODY ANIFROLUMAB

TRANSTHYRETIN ANTIBODIES AND USES THEREOF

ANTI-COMPLEMENT FACTOR C1Q FAB FRAGMENTS AND USES THEREOF

COMPOSITION FOR TREATING SOLID MALIGNANT TUMOR, AND KIT FOR TREATING SOLID MALIGNANT TUMOR

KIT OF KL-6 PROTEIN ON EXOSOMES FOR AUXILIARY DIAGNOSIS OF INTERSTITIAL LUNG DISEASE AND USE THEREOF

COMPOSITIONS AND METHODS FOR DETECTING AND TREATMENT OF MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS

Lateral Flow Device for Allograft Rejection

METHODS FOR TREATING CELLULAR INFLAMMATION INDUCED BY AFB1

ANTI-PD-1 ANTIBODY AND USE THEREOF

COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING METABOLIC DISEASES AND/OR A CLINICAL CONDITION THEREOF

Biomarkers For Lysosomal Storage Diseases

SYSTEM AND METHODS FOR PERFORMING SALIVA-BASED DIAGNOSTIC SCREENINGS

BIOMARKERS USEFUL IN THE TREATMENT OF SUBJECTS HAVING DISEASES OF THE EYE

METHOD FOR DETECTING KIDNEY DYSFUNCTION DIAGNOSTIC MARKER, METHOD FOR DETERMINING RENAL PROGNOSIS, DETECTION KIT FOR KIDNEY DYSFUNCTION DIAGNOSTIC MARKER, AND KIDNEY DYSFUNCTION DIAGNOSTIC MARKER

BIOMARKERS FOR DIAGNOSING TUBERCULOSIS

SEQUENTIAL TREATMENTS AND BIOMARKERS TO REVERSE RESISTANCE TO KINASE INHIBITORS

PROTEIN SIGNATURES FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS

MULTI-ARRAY IMPEDIMETRIC BIOSENSORS FOR THE DETECTION OF CONCUSSION AND TRAUMATIC BRAIN INJURIES

NON-INVASIVE MONITORING OF LIVER DISEASE TREATMENT

METHODS FOR DETECTING FRACTURE-RELATED INFECTION (FRI)

USE OF SOLUBLE TREM2 AS A NON-INVASIVE BIOMARKER FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH)

Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses Thereof

INHIBITORS FOR USE IN PREVENTION- AND/OR ALLEVIATION OF HEART FIBROSIS

NON-INVASIVE MONITORING OF LIVER DISEASE TREATMENT

Treatment Of Conditions Associated With Stress Granule Formation

MINIMALLY-INVASIVE MEASUREMENT OF ESOPHAGEAL INFLAMMATION

IVALTINOSTAT COMBINATION THERAPY FOR TREATING PANCREATIC CANCER

COMPOSITIONS, DEVICES, AND METHODS OF ECZEMA FOOD SENSITIVITY TESTING

METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES

BIOMARKER FOR CANCER DIAGNOSIS AND USE THEREOF

METHODS FOR ASSESSING TREATMENT WITH A GASTROINTESTINAL IMPLANT

Lung Cancer Prediction and Uses Thereof

ALLERGY ANTIGEN AND EPITOPE THEREOF

METHOD OF DIAGNOSING A CONDITION USING MICROBIOME DATA

CAIX TARGETING IL-12 FUSION PROTEINS AND METHODS OF USE THEREOF

ANTI-IL-23P19 ANTIBODY REGULATION OF GENES INVOLVED IN BOWEL URGENCY IN ULCERATIVE COLITIS

METHODS FOR DETERMINING RESPONSIVENESS TO TYK2 INHIBITORS

METHODS FOR DETERMINING DPP3 AND THERAPEUTIC METHODS

METHODS AND SYSTEMS FOR DETECTING URINARY TRACT INFECTIONS

ANTIBODIES

Method for Using a Marker Set for Determining the Risk of Kidney Rejection

EXTRAMAMMARY PAGET DISEASE BIOMARKERS AND USES THEREOF

ANTI-CK2a ANTIBODY OR A FRAGMENT THEREOF

ANTIBODIES AGAINST CLEAVED CDCP1 AND USES THEREOF

ASSAYS FOR ALPHA-DYSTROGLYCAN GLYCOSYLATION AND METHODS FOR USING SAME

ANTI-POLYUBIQUITIN MULTISPECIFIC ANTIBODIES

EARLY DIAGNOSIS OF INFECTIONS

METHODS AND COMPOSITIONS FOR TREATING SEPSIS

METHOD OF MODULATING THE ACTIVITY OF ADRENOMEDULLIN IN A SUBJECT IN NEED OF THERAPEUTIC INTERVENTION FOR ORGAN DYSFUNCTION OR ORGAN FAILURE ASSOCIATED WITH ADRENOMEDULLIN (ADM) ACTIVITY BY ADMINISTERING AN ANTI-ADRENOMEDULLIN (ADM) ANTIBODY OR AN ANTI-ADM FRAGMENT TO THE SUBJECT

COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE

Small Molecule Inhibitors of Formation of Neutrophil-Derived Extracellular Traps (NETosis) and Uses Thereof

DEVICES, SYSTEMS, AND METHODS FOR MEASURING BIOMARKERS IN BIOLOGICAL FLUIDS

BIOMARKERS FOR EARLY DIAGNOSIS OF CHRONIC HIP DISPLASIA AND METHODS OF USING THE SAME

NEWBORN SCREENING FOR CONGENITAL HEART DEFECT USING CARDIOVASCULAR BIOMARKERS IN DRIED BLOOD SAMPLES

DETECTION OF KDM1A LOSS OF ACTIVITY FOR DIAGNOSING ENDOCRINE DISORDERS

RENAL INJURY BIOMARKERS AS BIOMARKERS FOR ACUTE HEPATIC PORPHYRIA (AHP)

USE OF MECP2 AS BIOMARKER FOR DEPRESSION DIAGNOSIS AND DEPRESSION TREATMENT TARGET

DIAGNOSTIC METHOD OF BARRET'S OESOPHAGUS

Methods for Diagnosing and Treating Ischemic Eye Disease

BIOMARKERS TO DETECT RISK OF SINUSOIDAL OBSTRUCTION SYNDROME

Compositions and methods for detecting SARS-CoV-2 spike protein

DEVELOPMENT OF FLEXIBLE PLASMONIC MEMBRANE-BASED SERS PLATFORM FOR MONITORING THE HEALING

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY CONDITIONS

BIODOSIMETRY PANELS AND METHODS

DIAGNOSTIC BIOMARKER FOR CANCER AND USE THEREOF

ANTIGEN LATERAL FLOW

METHODS OF DIAGNOSING, PROGNOSING, AND TREATING MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) AND SEVERE COVID-19, AND APPARATUSES THEREOF

A METHOD OF PREDICTING RISK OF AN AGGRESSIVE OR RECURRENT CANCER

METHODS OF TREATING COPPER METABOLISM-ASSOCIATED DISEASES OR DISORDERS

METHOD FOR ESTIMATING THE PROBABILITY OF MALADAPTIVE GLOMERULAR IMPAIRMENT IN KIDNEY DISEASES

COMPOSITIONS AND TREATMENTS FOR CORONAVIRUS INFECTIONS

METHOD OF DETECTING PROTEINS IN HUMAN SAMPLES AND USES OF SUCH METHODS

ANTIBODIES SPECIFIC TO SIALIC ACID-BINDING IG-LIKE LECTIN 15 AND USES THEREOF

A CELL-BASED METHOD FOR DETECTING POTENTIALLY PATHOGENIC AUTOANTIBODIES TO NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS

CXC CHEMOKINE AGONISTS AND ANTAGONISTS IN COVID-19 DISEASE AND DIAGNOSTIC ASSAYS

SCREENING DONOR LUNGS FOR LUNG TRANSPLANTATION

METHOD FOR QUANTIFYING AHSP PROTEIN AND ITS USE FOR PROGNOSING A HAEMOGLOBIN-RELATED DISORDER

METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES

DEVICES AND METHODS FOR DIAGNOSISING THYROID MEDICAL CONDITIONS

Treatment Of Multiple Sclerosis And Neuromyelitis Optica

Immunomodulatory Therapy For Type 1 Diabetes Mellitus Autoimmunity

DIAGNOSTIC METHODS FOR HIDRADENITIS SUPPURATIVA

COMPOSITE BIOMARKER FOR THE IDENTIFICATION OF SELENIUM DEFICIENCY IN A BODILY FLUID

ANTIBODIES AND METHODS FOR THE DETECTION OF CELL DEATH

USE OF GLYCOPROTEIN ACETYLS FOR DETERMINING THE RISK OF DEVELOPING ATRIAL FIBRILLATION AND/OR FLUTTER

EVALUATION, ASSAYS AND TREATMENT OF PKALMEDIATED DISORDERS

METHODS FOR USING ENRICHED EXOSOMES AS A PLATFORM FOR MONITORING ORGAN STATUS

TGF- B receptor II isoform, fusion peptide, methods of treatment and methods in vitro

COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING OR AMELIORATING NONALCOHOLIC FATTY LIVER DISEASE AND RELATED DISEASES OR DISORDERS

Combination Therapy to Treat Temperature Sensitive Mutant Tumors

METHOD FOR PROVIDING INFORMATION RELATED TO TYPE OF CANCER, SYSTEM FOR PROVIDING INFORMATION RELATED TO TYPE OF CANCER

BIOMARKER FOR DETECTING TUBULOINTERSTITIAL DISORDER AND USE THEREOF

METABOLOMIC SIGNATURE FOR THE DIAGNOSIS OF ACUTE MESENTERIC ISCHEMIA

PAPER-BASED DEVICE AND USES THEREOF FOR MONITORING RECURRENCE OF CANCERS

METHODS FOR AIDING IN DIAGNOSING AND EVALUATING A MILD TRAUMATIC BRAIN INJURY IN A HUMAN SUBJECT USING CARDIAC TROPONIN I AND EARLY BIOMARKERS

Tuberculosis detection kit

BIOMARKERS AND METHODS FOR ASSESSING MYOCARDIAL INFARCTION AND SERIOUS INFECTION RISK IN RHEUMATOID ARTHRITIS PATIENTS

HYPOXIA BIOMARKER AND USE THEREOF

METHOD FOR DIAGNOSING AND TREATING METABOLIC DISORDERS

METHOD OF SIMULTANEOUSLY DIAGNOSING ACTIVE TUBERCULOSIS AND LATENT TUBERCULOSIS INFECTION USING HUMAN WHOLE BLOOD SAMPLE-DERIVED BIOMARKER

TGF-BETA INHIBITORS AND THERAPEUTIC USE THEREOF

IMMUNOSTIMULATORY BACTERIA FOR CONVERTING MACROPHAGES INTO A PHENOTYPE AMENABLE TO TREATMENT, AND COMPANION DIAGNOSTIC FOR IDENTIFYING SUBJECTS FOR TREATMENT

PLACENTAL CELL TREATMENT FOR CRITICAL LIMB ISCHEMIA PATIENT SUBPOPULATIONS

IN VITRO METHOD FOR PREDICTING MORTALITY RISK IN PATIENTS SUFFERING FROM SHOCK

METHODS FOR DIAGNOSING A CANCER- OR ANTIBIOTICS-INDUCED DYSBIOSIS AND THEIR USE FOR IMPROVING CANCER TREATMENT BY IMMUNOTHERAPY

Cardiovascular Disease

ANALYSIS OF VITREOUS SAMPLES TO GUIDE TREATMENT

METHOD FOR DIAGNOSING FIBRINOLYTIC INSUFFICIENCY RELATED TO NEUTROPHIL EXTRACELLULAR TRAPS

BIOMARKERS PREDICTIVE OF CYTOKINE RELEASE SYNDROME

METHOD FOR PREDICTING RISK FOR THROMBOSIS IN CANCER PATIENT USING SOLUBLE CLEC2

Cancer treatment

Translational Activators, Including Methods of Discovery and Uses Thereof

METHODS AND DEVICES FEMALE HEALTH MONITORING

A METHOD FOR PREDICTING SEPSIS AND SEPTIC SHOCK

sFRP4 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ADENOMYOSIS

INTEGRATED METHOD FOR URINARY PROSTATE SPECIFIC ANTIGEN N-GLYCOSYLATION PROFILING BY CAPILLARY ELECTROPHORESIS

METHODS FOR PREDICTING RISK OF INTERSTITIAL PNEUMONIA

NOVEL ANTI-CLAUDIN18 ANTIBODIES

PROPHYLACTIC OR THERAPEUTIC AGENT FOR ACUTE RENAL FAILURE

METHOD OF PROGNOSIS

Compositions and Methods for Identifying and Modulating Metabolic Health

Enhanced expression of polo-like kinase 3 (PLK3) in human immunodeficiency virus (HIV)-infected cells

METHOD FOR PREDICTING DEVELOPMENT OF SEVERE SYMPTOM OF COVID-19 USING EXOSOMAL PROTEIN MARKER IN BLOOD

Biomarkers for the Detection of Thrombosis or Coagulation-Related Disorders and Their Applications

NOVEL ASSAY AND NOVEL METHODS OF TREATING AGING-RELATED CONDITIONS

FIBROSIS BIOMARKERS FOR NON-ALCOHOLIC FATTY LIVER DISEASE

QUANTITATIVE PARTICLE AGGLUTINATION ASSAY USING PORTABLE HOLOGRAPHIC IMAGING AND DEEP LEARNING

Assays For Determining Severity Of Peanut Allergies

BIOMARKER FOR IN VITRO DIAGNOSIS AND/OR PROGNOSIS OF A SYSTEMIC INFLAMMATION

Renal Insufficiency Prediction and Uses Thereof

Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy

TREATMENT METHODS HAVING REDUCED DRUG-RELATED TOXICITY AND METHODS OF IDENTIFYING THE LIKELIHOOD OF PATIENT HARM FROM PRESCRIBED MEDICATIONS

Human Anti-SOD1 Antibodies

BIOMARKERS FOR AGE-RELATED MACULAR DEGENERATION

NGAL MARKER PANELS FOR EARLY DETECTION OF SEPSIS

METHOD AND DEVICE FOR DETECTING SIGLEC12

PROTEOMIC SAMPLE INVESTIGATION METHOD FOR DIAGNOSING RHABDOMYOLYSIS AND KITS FOR IMPLEMENTING SAME

METHOD FOR EXAMINING PROGRESSION OF CHRONIC KIDNEY DISEASE IN SUBJECT, AND KIT

Antibody Combination Against Regenerating Islet-Derived Protein 1a And Detection Kit Comprising Same

PATCHED-1 MONOCLONAL ANTIBODIES AND METHODS OF USE

IMMUNOTHERAPY FOR INFLAMMATORY BOWEL DISEASE AND/OR CANCER

METHODS OF REGULATING BCL11A EXPRESSION AND TREATMENT OF BCL11A-MEDIATED DISORDERS

Protein Biomarkers For Non-Alcoholic Fatty Liver Disease (NAFLD)

ESM1 MARKER PANELS FOR EARLY DETECTION OF SEPSIS

SFLT1 MARKER PANELS FOR EARLY DETECTION OF SEPSIS

STREM1 MARKER PANELS FOR EARLY DETECTION OF SEPSIS

GDF15 MARKER PANELS FOR EARLY DETECTION OF SEPSIS

PRESEPSIN MARKER PANELS FOR EARLY DETECTION OF SEPSIS

COMPOSITIONS AND METHODS FOR IDENTIFICATION OF CROSS-REACTIVE ALLERGENIC PROTEINS AND TREATMENT OF ALLERGIES

Markers for renal disease

COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE

METHODS FOR ASSESSING MUCOSAL HEALING IN INFLAMMATORY BOWEL DISEASE PATIENTS

SEQUENCING MICROBIAL CELL-FREE NUCLEIC ACIDS TO DETECT INFLAMMATION, SECONDARY INFECTION, AND DISEASE SEVERITY

Aptamer for specifically recognizing soluble ST2 protein and application of the same

VON WILLEBRAND FACTOR (VWF) INHIBITORS

PCT MARKER PANELS FOR EARLY DETECTION OF SEPSIS

IL6 MARKER PANELS FOR EARLY DETECTION OF SEPSIS

IGFBP7 MARKER PANELS FOR EARLY DETECTION OF SEPSIS

METHODS FOR INHIBITING KRAS ONCOPROTEIN THROUGH ENHANCED GTPASE ACTIVITY

METHODS FOR THE DETERMINATION OF THE PREDISPOSITION FOR A SEVERE OR CRITICAL COURSE OF A COVID-19-DISEASE FROM A MILD OR MODERATE COURSE OF A COVID-19-DISEASE IN A SUBJECT

DIFFERENTIAL DIAGNOSIS OF HISTAMINE INTOLERANCE SYNDROME

DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS ASSOCIATED WITH ALTERED METABOLIC PATHWAYS

PLASMA THERMOGRAMS FOR DIAGNOSIS AND TREATMENT OF ACUTE MYOCARDIAL INFARCTION

APPLICATION OF CRMP2 AND ANTI-CRMP2 ANTIBODY

INHIBITORY NUCLEIC ACIDS FOR FACTOR H FAMILY PROTEINS

PATIENT SELECTION METHODS AND KITS FOR THERAPIES TARGETING TL1A

METHODS FOR TREATING CHOLESTASIS

COMPOSITIONS AND METHODS FOR TREATING INDIVIDUALS WHO HAVE ONCOGENE-NEGATIVE CANCER

COMPOSITION FOR DIAGNOSIS OR TREATMENT OF ANTICANCER DRUG RESISTANCE

ANALYSIS OF EFFLUENT

PRODUCTS AND METHODS FOR TREATING MUSCULAR DYSTROPHY

METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST

UV A LIGHT EXPOSURE INCREASES MITOCHONDRIAL ANTI-VIRAL PROTEIN EXPRESSION IN TRACHEAL CELLS VIA CELL-TO-CELL COMMUNICATION AND USES THEREOF

BINDING PROTEINS RECOGNIZING HA-2 ANTIGEN AND USES THEREOF

THERAPEUTIC USES OF DULAGLUTIDE

USE OF THE EXTRACELLULAR DOMAIN OF TRANSFERRIN RECEPTOR 2 FOR THE DIAGNOSIS AND TREATMENT OF PRIMARY OR SECONDARY SCLEROSING DISEASES

TREATMENT OF CIRCADIAN RHYTHM DISORDERS

METHODS OF DIAGNOSING AND PREDICTING RENAL DECLINE

METHODS FOR TREATING CHOLESTASIS

ELISA Assay for Measuring Function of Properdin and Kits for Conducting ELISA Assays using Anti-properdin Antibodies

USE OF GLYCOPROTEIN ACETYLS FOR DETERMINING THE RISK OF DEVELOPING A GALLBLADDER DISORDER

RUNX1 Inhibition for Treatment of Proliferative Vitreoretinopathy and Conditions Associated with Epithelial to Mesenchymal Transition

Determining a cardiovascular ischemic event and decision support tool

METHOD OF DETERMINING PROGNOSIS OF CHRONIC KIDNEY DISEASE

METHOD OF PROGNOSIS

METHODS OF DETECTING SYSTEMIC AMYLOIDOSIS VIA BINDING TO MISFOLDED OR AGGREGATED PROTEIN

WASTEWATER-BASED EPIDEMIOLOGY METHODS FOR ASSESSING POPULATION HEALTH

METHODS FOR COLORECTAL CANCER DIAGNOSIS AND PROGNOSIS

METHOD FOR DIAGNOSING PRIMARY BILIARY CIRRHOSIS (PBC) USING NOVEL AUTOANTIGENS

COLON CANCER DIAGNOSIS OR DETECTION COMPOSITION FOR PREDICTING RESPONSE TO DRUG, AND COMPOSITION FOR PREVENTING OR TREATING COLON CANCER

MEANS AND METHODS FOR ASSESSING IMMUNOTHERAPY

METHODS AND COMPOSITIONS FOR TREATING CELL SENESCENCE ACCUMULATION RELATED DISEASE

METHOD FOR INDUCING AND DETECTING SOLUBLE LOX-1 (sLOX-1) IN CULTURED BLOOD CLOTS

FLAVIVIRUS PEPTIDE SEQUENCES, EPITOPES, AND METHODS AND USES THEREOF

Treatment of circadian rhythm disorders

METHOD FOR DETECTING OR QUANTIFYING PHOTOAGED CELLS, APPLICATION OF SAME, AND METHOD FOR PREPARING PHOTOAGED CELLS

TISSUE TESTER

DIAGNOSIS OF RESPIRATORY DISEASES BY CAPTURING AEROSOLIZED BIOMATERIAL PARTICLES USING PACKED BED SYSTEMS AND METHODS

METABOLIC BIOMARKERS FOR ASSESSING HEART FAILURE IN A SINGLE VENTRICLE PEDIATRIC SUBJECT

PROTEIN BIOMARKERS FOR DISEASES ASSOCIATED WITH THE CONTACT ACTIVATION SYSTEM

Use of Biomarkers in the Treatment of Fibrotic Conditions with a PDE4B-inhibitor

URINARY TRACT INFECTION DIAGNOSTIC

ALPHA-1 ANTITRYPSIN (AAT) RNAI AGENTS, COMPOSITIONS INCLUDING AAT RNAI AGENTS, AND METHODS OF USE

USE OF ENHANCED TBX1 EXPRESSION IN REPAIRING HEART TISSUE INJURY

NOVEL METHOD AND AGENT FOR TREATING, DIAGNOSING AND DETECTING DIABETES AND COMPLICATIONS

COMPOSITIONS AND METHODS FOR IDENTIFICATION OF CROSS-REACTIVE ALLERGENIC PROTEINS AND TREATMENT OF ALLERGIES

COMPOSITIONS AND METHODS FOR IDENTIFYING AND MODULATING THROMBOTIC CONDITIONS IN A CANCER PATIENT

SEQUENCING MICROBIAL CELL-FREE NUCLEIC ACIDS TO DETECT INFLAMMATION, SECONDARY INFECTION, AND DISEASE SEVERITY

METHOD AND SYSTEM FOR PROVIDING INFORMATION ABOUT VIRUS INFECTION AND/OR VIRUS INFECTION DISEASES

NOVEL DIAGNOSTIC AND METHOD OF SCREENING THERAPEUTICS FOR FIBROTIC CONDITIONS

Immunoassay for Detecting Eosinophilic Esophagitis

MARKER FOR DIAGNOSIS OF NONALCOHOLIC FATTY LIVER DISEASE

NANOSENSORS FOR RAPID IDENTIFICATION OF LUNG CONDITIONS

Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell

PROTEIN AND METABOLITE BLOOD BIOMARKERS FOR THE DIAGNOSIS OF BRUGADA SYNDROME

DOSING ALGORITHM FOR COMPLEMENT INHIBITOR

LIPOPEPTIDES FOR USE IN TREATING LIVER DISEASES AND CARDIOVASCULAR DISEASES

Biomarkers for diagnosing non-alcoholic steatohepatitis (NASH) or hepatocellular carcinoma (HCC)

BIOMARKERS OF RENAL INJURY

HUMORAL ANTIBODY BIOMARKER FOR DETECTING ARTERY LESIONS, AND DETECTING CEREBROVASCULAR AND CARDIOVASCULAR DISORDER, DIABETES, CHRONIC NEPHROPATHY, OR SOLID CANCER

METHODS OF DIAGNOSING OR AIDING IN DIAGNOSIS OF BRAIN INJURY CAUSED BY ACOUSTIC ENERGY, ELECTROMAGNETIC ENERGY, AN OVER PRESSURIZATION WAVE, AND/OR BLAST WIND

Peptides And Use Thereof For Diagnosing And Treating Antiphospholipid Syndrome

BILE SALTS BACTOSENSOR AND USE THEREOF FOR DIAGNOSITC AND THERAPEUTIC PURPOSES

COMPOSITION FOR PREVENTION OR TREATMENT OF KIDNEY DISEASE

SCREENING KIT AND DIAGNOSIS SYSTEM FOR PRIMARY ALDOSTERONISM

BIOMARKERS AND METHODS FOR DIFFERENTIATING BETWEEN MILD AND SUPERMILD TRAUMATIC BRAIN INJURY

END STAGE RENAL DISEASE BIOMARKER PANEL

METHOD FOR TREATING HEPATOCELLULAR CARCINOMA